Patent · US Active

Neisseria meningitidis antigens and compositions

US8524251B2 · kind B2 · utility

24Cited by
9References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 26, 2012
Grant dateSep 3, 2013
Priority date
Expiry dateJan 26, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/825
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.